For people struggling with cognitive impairment, finding ways to sharpen memory and thinking is a daily challenge. A large review looked at a specific technique called transcranial direct current stimulation, or tDCS. This method uses a mild electrical current to gently stimulate the brain while the person does cognitive training exercises. The goal was to see if adding this stimulation to regular training would work better than training alone. The analysis included data from 1,012 individuals. The results showed a small improvement in cognitive function when stimulation was added. However, this boost was not huge compared to doing the training by itself. The researchers noted that this small effect might help people in the short term, but it does not represent a massive breakthrough. It is important to remember that the benefit did not last as long as hoped. The advantage of the stimulation faded away during follow-up periods, suggesting the gains were temporary. Because the studies varied greatly in how they were done, the overall picture remains a bit unclear. While the method seems safe with no reported serious side effects, the clinical value is limited by how quickly the effects wear off.
Systematic review finds small short-term cognitive benefit from tDCS plus trainingAdding stimulation to training offers small, short-term help for memory in cognitive impairment
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This systematic review and meta-analysis investigated the efficacy of transcranial direct current stimulation (tDCS) combined with cognitive training compared to cognitive training alone in individuals with cognitive impairment. The analysis included data from 1012 participants, though the specific setting was not reported. The primary outcome measured was cognitive function.
The meta-analysis demonstrated a small positive effect size for the combined intervention relative to training alone, with a standardized mean difference (SMD) of 0.36 and a 95% confidence interval ranging from 0.15 to 0.56. Absolute numbers for this outcome were not reported in the source data.
The authors highlight significant limitations, including high heterogeneity across the included studies and a loss of effect observed at follow-up. Adverse events, discontinuations, and tolerability were not reported. Furthermore, the review did not provide a certainty note or specific funding disclosures.
Given these constraints and the small magnitude of the observed benefit, the practice relevance is that tDCS combined with cognitive training may provide a small, short-term benefit for cognitive function. Clinicians should interpret these findings cautiously, noting that the clinical value is not definitively established.
View Original Abstract ↓
Intravenous tenecteplase improves functional outcomes but increases hemorrhage risk in non-large vessel occlusion acute ischemic stroke
Tenecteplase improves stroke recovery but increases bleeding risk in late treatment window
Related in Neurology
From Other Specialties
